Dwayne C. Jones

Array ( [id] => 4269695 [patent_doc_number] => 06306894 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Injectable composition' [patent_app_type] => 1 [patent_app_number] => 9/563969 [patent_app_country] => US [patent_app_date] => 2000-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1059 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/306/06306894.pdf [firstpage_image] =>[orig_patent_app_number] => 563969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1475277 [patent_doc_number] => 06387955 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones' [patent_app_type] => B1 [patent_app_number] => 09/562949 [patent_app_country] => US [patent_app_date] => 2000-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 13 [patent_no_of_words] => 7354 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 231 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387955.pdf [firstpage_image] =>[orig_patent_app_number] => 09562949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7640135 [patent_doc_number] => 06395780 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Cleavage system inhibitors as potential antipsychotics' [patent_app_type] => B1 [patent_app_number] => 09/559831 [patent_app_country] => US [patent_app_date] => 2000-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 2232 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395780.pdf [firstpage_image] =>[orig_patent_app_number] => 09559831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1416716 [patent_doc_number] => 06521640 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-18 [patent_title] => 'Method for interviewing neuronal death using sulfasalazine' [patent_app_type] => B1 [patent_app_number] => 09/556525 [patent_app_country] => US [patent_app_date] => 2000-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 5250 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/521/06521640.pdf [firstpage_image] =>[orig_patent_app_number] => 09556525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4396873 [patent_doc_number] => 06297244 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-02 [patent_title] => 'Stable drug composition' [patent_app_type] => 1 [patent_app_number] => 9/529719 [patent_app_country] => US [patent_app_date] => 2000-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2842 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/297/06297244.pdf [firstpage_image] =>[orig_patent_app_number] => 529719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 472856 [patent_doc_number] => 07230014 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-06-12 [patent_title] => 'Pharmaceutical formulation comprising glycine as a stabilizer' [patent_app_type] => utility [patent_app_number] => 09/549858 [patent_app_country] => US [patent_app_date] => 2000-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 4328 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/230/07230014.pdf [firstpage_image] =>[orig_patent_app_number] => 09549858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1560344 [patent_doc_number] => 06361800 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-26 [patent_title] => 'Multi-vitamin and mineral supplement' [patent_app_type] => B1 [patent_app_number] => 09/548914 [patent_app_country] => US [patent_app_date] => 2000-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7347 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 246 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/361/06361800.pdf [firstpage_image] =>[orig_patent_app_number] => 09548914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4269448 [patent_doc_number] => 06306879 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Stable aqueous solution of 3-(1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2-6-dione' [patent_app_type] => 1 [patent_app_number] => 9/540203 [patent_app_country] => US [patent_app_date] => 2000-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1645 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/306/06306879.pdf [firstpage_image] =>[orig_patent_app_number] => 540203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1475077 [patent_doc_number] => 06387916 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Anti-inflammatory uses of manzamines' [patent_app_type] => B1 [patent_app_number] => 09/535291 [patent_app_country] => US [patent_app_date] => 2000-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4829 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 239 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387916.pdf [firstpage_image] =>[orig_patent_app_number] => 09535291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4422051 [patent_doc_number] => 06225333 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-01 [patent_title] => 'Method of treatment of pigmented cancer cells utilizing photodynamic therapy' [patent_app_type] => 1 [patent_app_number] => 9/524824 [patent_app_country] => US [patent_app_date] => 2000-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 4968 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/225/06225333.pdf [firstpage_image] =>[orig_patent_app_number] => 524824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1475267 [patent_doc_number] => 06387953 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Inhibition of TNF-()-initiated neutrophil response' [patent_app_type] => B1 [patent_app_number] => 09/525291 [patent_app_country] => US [patent_app_date] => 2000-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13746 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 508 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387953.pdf [firstpage_image] =>[orig_patent_app_number] => 09525291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1524183 [patent_doc_number] => 06353026 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-05 [patent_title] => 'Regulation of phospholipase D activity' [patent_app_type] => B1 [patent_app_number] => 09/525157 [patent_app_country] => US [patent_app_date] => 2000-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15193 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 511 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/353/06353026.pdf [firstpage_image] =>[orig_patent_app_number] => 09525157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4312922 [patent_doc_number] => 06316489 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Salt of (2R,3R,4R)-3,4-dihydroxy-2-hydroxymethylpyrrolidine' [patent_app_type] => 1 [patent_app_number] => 9/523012 [patent_app_country] => US [patent_app_date] => 2000-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3985 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316489.pdf [firstpage_image] =>[orig_patent_app_number] => 523012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1169916 [patent_doc_number] => 06753341 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-22 [patent_title] => 'Inhibition of PKC to treat permability failure' [patent_app_type] => B1 [patent_app_number] => 09/524459 [patent_app_country] => US [patent_app_date] => 2000-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 1766 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/753/06753341.pdf [firstpage_image] =>[orig_patent_app_number] => 09524459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 961160 [patent_doc_number] => 06951873 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-10-04 [patent_title] => 'Methods for treating age-related behavioral disorders in companion animals' [patent_app_type] => utility [patent_app_number] => 09/518408 [patent_app_country] => US [patent_app_date] => 2000-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4641 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/951/06951873.pdf [firstpage_image] =>[orig_patent_app_number] => 09518408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4331708 [patent_doc_number] => 06313170 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-06 [patent_title] => 'L-threonate ferrous, as well as pharmaceutical composition and use for improving and treating human anemia thereof' [patent_app_type] => 1 [patent_app_number] => 9/486569 [patent_app_country] => US [patent_app_date] => 2000-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6433 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/313/06313170.pdf [firstpage_image] =>[orig_patent_app_number] => 486569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1380894 [patent_doc_number] => 06555547 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-29 [patent_title] => 'Method for treating a patient with neoplasia by treatment with a vinca alkaloid derivative' [patent_app_type] => B1 [patent_app_number] => 09/515714 [patent_app_country] => US [patent_app_date] => 2000-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 41 [patent_no_of_words] => 21898 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/555/06555547.pdf [firstpage_image] =>[orig_patent_app_number] => 09515714 [rel_patent_id] =>[rel_patent_doc_number] =>)